Victoria A Ploplis Selected Research

Victoria A Ploplis Research Topics

Disease

15	Infections 03/2024 - 08/2003
9	Inflammation (Inflammations) 03/2024 - 12/2006
7	Neoplasms (Cancer) 01/2011 - 02/2003
5	Atherosclerosis 12/2021 - 05/2006
4	Thrombosis (Thrombus) 10/2014 - 12/2006
3	Sepsis (Septicemia) 03/2024 - 01/2015
3	Streptococcal Infections (Streptococcal Infection) 01/2022 - 01/2013
3	Fibrosis (Cirrhosis) 01/2017 - 08/2003
3	Adenoma (Adenomas) 07/2008 - 02/2003
2	Urinary Tract Infections (Urinary Tract Infection) 03/2024 - 09/2023
2	Cross Infection (Nosocomial Infection) 03/2024 - 09/2023
2	Bacterial Infections (Bacterial Infection) 02/2024 - 01/2013
2	Hemolysis 01/2022 - 01/2016
2	Wounds and Injuries (Trauma) 01/2021 - 06/2016
2	Endotoxemia 01/2015 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 01/2011 - 11/2003
2	Necrosis 02/2010 - 12/2006
2	Respiratory Hypersensitivity 05/2009 - 01/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2008 - 11/2003
2	Carcinoma (Carcinomatosis) 11/2003 - 02/2003
2	Carcinogenesis 11/2003 - 02/2003
1	Wound Infection (Wound Infections) 02/2024
1	Communicable Diseases (Infectious Diseases) 02/2024
1	Pulmonary Hypertension 01/2023
1	Vascular Remodeling 01/2023
1	Familial Primary Pulmonary Hypertension 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hypercholesterolemia 12/2021
1	Tics (Tic) 06/2019
1	Hypertension (High Blood Pressure) 01/2017
1	Multiple Trauma (Multiple Injuries) 06/2016
1	Pulmonary Edema 01/2016
1	Lung Injury 01/2016
1	Pathologic Processes 04/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
7	FibrinIBA 03/2024 - 08/2003
6	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 03/2010
5	PlasminogenIBA 12/2021 - 08/2003
4	Fibrinogen (Factor I)FDA Link 03/2024 - 05/2006
4	Thrombin FDA Link 06/2019 - 05/2006
4	Protein CIBA 06/2019 - 12/2006
3	streptolysin SIBA 01/2022 - 01/2016
3	CollagenIBA 01/2017 - 01/2007
3	Plasminogen Activator Inhibitor 1IBA 01/2017 - 03/2010
3	Fibrinolysin FDA Link 01/2017 - 08/2003
3	Adenosine Diphosphate (ADP)IBA 10/2014 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2008
2	Fibrin Fibrinogen Degradation ProductsIBA 01/2022 - 03/2008
2	oxidized low density lipoproteinIBA 12/2021 - 01/2018
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2017
2	LDL CholesterolIBA 01/2018 - 05/2006
2	Apolipoprotein B-100 (Apo B 100)IBA 01/2018 - 05/2006
2	Apolipoprotein B-48IBA 01/2018 - 05/2006
2	ApolipoproteinsIBA 01/2018 - 05/2006
2	LDL Receptors (LDL Receptor)IBA 01/2018 - 05/2006
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 01/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 01/2013
2	Fibronectins (Fibronectin)IBA 01/2017 - 08/2003
2	Thromboplastin (Tissue Factor)IBA 01/2011 - 05/2009
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2011 - 07/2008
2	Sulindac (Copal)FDA LinkGeneric 01/2011 - 07/2008
2	MucinsIBA 05/2009 - 01/2007
2	Factor X (Stuart Factor)IBA 05/2009 - 01/2007
2	Extracellular Matrix ProteinsIBA 08/2003 - 02/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Antimicrobial PeptidesIBA 02/2024
1	sphingosine kinaseIBA 01/2023
1	SphingolipidsIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Sodium-Bicarbonate SymportersIBA 01/2022
1	Chloride-Bicarbonate AntiportersIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	Apolipoproteins E (ApoE)IBA 12/2021
1	IntegrinsIBA 01/2021
1	Streptokinase FDA Link 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2019
1	ThrombomodulinIBA 06/2019
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 06/2019
1	CytokinesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	AldosteroneIBA 01/2017
1	Angiotensin IIIBA 01/2017
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2017
1	Enzyme Precursors (Zymogens)IBA 01/2017
1	Complement System Proteins (Complement)IBA 04/2016
1	IonsIBA 01/2016
1	AnionsIBA 01/2016
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	AntithrombinsIBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	lepirudin (Refludan)FDA Link 01/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2015
1	VitronectinIBA 01/2015

Therapy/Procedure

2	Catheters 03/2024 - 09/2023
2	Therapeutics 01/2022 - 06/2016
1	Resuscitation 06/2016